Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Commentary on Wagener et‚ÄČal. (2012): laissez-faire regulation: turning back the clock on the Food and Drug Administration and public health.

Cobb NK, Abrams DB.

Addiction. 2012 Sep;107(9):1552-4. doi: 10.1111/j.1360-0443.2012.03927.x. Epub 2012 May 17. No abstract available.

PMID:
22594851
2.

Commentary on Wagener et al. (2012): E-cigarettes: a vulnerable promise.

Hajek P.

Addiction. 2012 Sep;107(9):1549. doi: 10.1111/j.1360-0443.2012.03899.x. Epub 2012 May 17. No abstract available.

PMID:
22594603
3.

Commentary on Wagener et al. (2012): E-cigarettes: room for cautious optimism.

Bauld L.

Addiction. 2012 Sep;107(9):1549-50. doi: 10.1111/j.1360-0443.2012.03904.x. Epub 2012 May 17. No abstract available.

PMID:
22594634
4.

Commentary on Wagener et al. (2012): electronic cigarettes - the Holy Grail of nicotine replacement?

Etter JF.

Addiction. 2012 Sep;107(9):1550-2. doi: 10.1111/j.1360-0443.2012.03909.x. Epub 2012 May 17. No abstract available.

PMID:
22594671
5.

Response to Anandarajan et al.: Manic exacerbation induced by nicotine patch.

Filia SL, Gurvich CT, Baker AL, Kulkarni J.

Aust N Z J Psychiatry. 2012 May;46(5):484-5. doi: 10.1177/0004867412444627. Epub 2012 Apr 3. No abstract available.

PMID:
22472771
6.

Electronic cigarettes: achieving a balanced perspective.

Wagener TL, Siegel M, Borrelli B.

Addiction. 2012 Sep;107(9):1545-8. doi: 10.1111/j.1360-0443.2012.03826.x. Epub 2012 Apr 4.

PMID:
22471757
7.

Pfizer advertises smoking cessation drug despite health warnings.

Eggertson L.

CMAJ. 2012 Feb 7;184(2):E127-8. doi: 10.1503/cmaj.109-4087. Epub 2012 Jan 16. No abstract available.

8.

Pharmacologic approaches to smoking cessation.

Bailey AM, Macaulay T.

Orthopedics. 2012 Jun;35(6):505-11. doi: 10.3928/01477447-20120525-07.

PMID:
22691640
9.

Let's keep our 'eye on the ball': reducing tobacco-related harm.

Wagener TL, Siegel M, Borrelli B.

Addiction. 2012 Sep;107(9):1554-5. doi: 10.1111/j.1360-0443.2012.04012.x. No abstract available.

PMID:
22861672
10.

Manic exacerbation induced by nicotine patch.

Anandarajan T, Tibrewal P, Dhillon R.

Aust N Z J Psychiatry. 2012 Apr;46(4):389. doi: 10.1177/0004867411432216. Epub 2012 Jan 5. No abstract available.

PMID:
22508602
11.

Electronic cigarettes: the potential risks outweigh the benefits.

van Zyl-Smit RN.

S Afr Med J. 2013 Sep 30;103(11):833. doi: 10.7196/samj.7435. No abstract available.

PMID:
24148178
12.

The destructiveness of laissez-faire leadership behavior.

Skogstad A, Einarsen S, Torsheim T, Aasland MS, Hetland H.

J Occup Health Psychol. 2007 Jan;12(1):80-92.

PMID:
17257068
13.

Lessons learned from independent central review.

Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, Rubinstein L, Sargent D, Shankar L, Therasse P, Verweij J.

Eur J Cancer. 2009 Jan;45(2):268-74. doi: 10.1016/j.ejca.2008.10.031.

PMID:
19101138
14.

Nicotine patches--do they influence seizure number, stay durations or seizure rate during video EEG telemetry?

Parikh MS, Haltiner AM, de Menezes MS, Caylor LM, Sepkuty JP, Simon EA, Schoenfeld JL, Doherty MJ.

Epilepsy Behav. 2012 Mar;23(3):389-91. doi: 10.1016/j.yebeh.2011.12.007. Epub 2012 Feb 15. No abstract available.

PMID:
22341182
15.

Electronic cigarettes: the potential benefits outweigh the risks.

Allwood B.

S Afr Med J. 2013 Sep 30;103(11):832-3. doi: 10.7196/samj.7434. No abstract available.

PMID:
24148166
16.

Tobacco psychopharmacology and public health policy: it takes a community.

Henningfield JE.

Exp Clin Psychopharmacol. 2011 Aug;19(4):249-62. doi: 10.1037/a0024316. Review.

PMID:
21728446
17.

The emerging phenomenon of electronic cigarettes.

Caponnetto P, Campagna D, Papale G, Russo C, Polosa R.

Expert Rev Respir Med. 2012 Feb;6(1):63-74. doi: 10.1586/ers.11.92. Review.

PMID:
22283580
18.

Commentary on Higashi & Barendregt (2012): Smoking cessation therapies in Vietnam.

Pollack HA.

Addiction. 2012 Mar;107(3):671-2. doi: 10.1111/j.1360-0443.2012.03764.x. No abstract available.

PMID:
22313108
19.

Laissez-faire: how far can you go?

DaCosta J, Oworu O, Jones CA.

Orbit. 2009;28(1):12-5. doi: 10.1080/01676830802417510.

PMID:
19229738
20.

Grover disease may result from the impairment of keratinocytic cholinergic receptors.

Paslin D.

J Am Acad Dermatol. 2012 Feb;66(2):332-3. doi: 10.1016/j.jaad.2009.08.015. No abstract available.

PMID:
22243730

Supplemental Content

Support Center